|
|
Volumn 10, Issue 5, 2011, Pages 337-
|
|
Autoimmune diseases: New route to targeting TNF
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
ATSTTRIN;
PROGRANULIN;
RECOMBINANT PROGRANULIN;
TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR INHIBITOR;
TUMOR NECROSIS FACTOR RECEPTOR;
TUMOR NECROSIS FACTOR RECEPTOR 2;
UNCLASSIFIED DRUG;
ANTIINFLAMMATORY ACTIVITY;
BINDING AFFINITY;
DISEASE COURSE;
DRUG EFFICACY;
DRUG SELECTIVITY;
DRUG TOLERABILITY;
NONHUMAN;
NOTE;
PHARMACOLOGICAL BLOCKING;
PRIORITY JOURNAL;
PROTEIN BINDING;
PROTEIN FUNCTION;
PROTEIN TARGETING;
RHEUMATOID ARTHRITIS;
SINGLE DRUG DOSE;
TREATMENT RESPONSE;
|
|
EID: 79955585070
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3449 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
